U.S. markets open in 7 hours 14 minutes
  • S&P Futures

    4,365.00
    +16.75 (+0.39%)
     
  • Dow Futures

    34,006.00
    +167.00 (+0.49%)
     
  • Nasdaq Futures

    15,055.75
    +46.25 (+0.31%)
     
  • Russell 2000 Futures

    2,188.60
    +11.80 (+0.54%)
     
  • Crude Oil

    70.90
    +0.61 (+0.87%)
     
  • Gold

    1,763.40
    -0.40 (-0.02%)
     
  • Silver

    22.27
    +0.07 (+0.32%)
     
  • EUR/USD

    1.1740
    +0.0012 (+0.11%)
     
  • 10-Yr Bond

    1.3090
    0.0000 (0.00%)
     
  • Vix

    25.71
    +4.90 (+23.55%)
     
  • GBP/USD

    1.3677
    +0.0018 (+0.13%)
     
  • USD/JPY

    109.5550
    +0.1350 (+0.12%)
     
  • BTC-USD

    42,757.53
    -2,924.52 (-6.40%)
     
  • CMC Crypto 200

    1,068.96
    -65.43 (-5.77%)
     
  • FTSE 100

    6,903.91
    -59.73 (-0.86%)
     
  • Nikkei 225

    29,854.67
    -645.38 (-2.12%)
     

Better Biotech Stock: Moderna vs. BioNTech

·5 min read
Better Biotech Stock: Moderna vs. BioNTech
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Not only did they develop the first two COVID vaccines authorized by the Food and Drug Administration, they used messenger RNA (mRNA). The technology had never been approved for a vaccine in humans. Moderna went public in 2018 in what was to that point the largest biotech initial public offering (IPO) in history.